Literature DB >> 12756133

Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.

Maria-Jesús Sobrido1, Bruce L Miller, Necat Havlioglu, Victoria Zhukareva, Zhihong Jiang, Ziad S Nasreddine, Virginia M-Y Lee, Tiffany W Chow, Kirk C Wilhelmsen, Jeffrey L Cummings, Jane Y Wu, Daniel H Geschwind.   

Abstract

BACKGROUND: A subset of familial cases (FTDP-17) of frontotemporal dementia (FTD) are caused by mutations in the tau gene. The role of tau gene mutations and haplotypes in sporadic FTD and the functional consequences of tau polymorphisms are unknown.
OBJECTIVES: To investigate (1) the frequency of known FTDP-17 mutations in familial and sporadic FTD and compare these results with previous studies; (2) whether the tau H1 haplotype is associated with FTD; and (3) the functional effect of intronic tau sequence variations. PATIENTS AND METHODS: Patients with familial and sporadic FTD were screened for mutations in the microtubule-binding region of tau. The frequencies of tau haplotypes and genotypes were compared between patients with FTD and control subjects. We analyzed the splicing effect of novel intronic polymorphisms associated with FTD.
RESULTS: The P301L mutation was detected in 11% of familial FTD cases. The H1 haplotype was not overrepresented in patients with FTD, but the P301L mutation appeared on the background of the H2 tau haplotype. We identified 4 novel single nucleotide polymorphisms in intron 9 and a 9-base pair deletion in intron 4A. A C-to-T transition 177 base pairs upstream from exon 10 was significantly increased in patients with FTD compared with controls. Direct analysis of brain tissue from a patient with this variant showed an increase in exon 10-containing tau transcripts.
CONCLUSIONS: Sequence variations in intronic or regulatory regions of tau may have previously unrecognized consequences leading to tau dysfunction and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756133      PMCID: PMC2072863          DOI: 10.1001/archneur.60.5.698

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  21 in total

1.  Possible association of the tau H1/H1 genotype with primary progressive aphasia.

Authors:  M-J Sobrido; A Abu-Khalil; S Weintraub; N Johnson; B Quinn; J L Cummings; M-M Mesulam; D H Geschwind
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

2.  Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease.

Authors:  L Lilius; S Froelich Fabre; H Basun; C Forsell; K Axelman; K Mattila; A Andreadis; M Viitanen; B Winblad; L Fratiglioni; L Lannfelt
Journal:  Neurosci Lett       Date:  1999-12-17       Impact factor: 3.046

3.  Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.

Authors:  Z Jiang; J Cote; J M Kwon; A M Goate; J Y Wu
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations.

Authors:  B L Miller; C Ikonte; M Ponton; M Levy; K Boone; A Darby; N Berman; I Mena; J L Cummings
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

5.  The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease.

Authors:  C Russ; S Lovestone; M Baker; S M Pickering-Brown; P M Andersen; R Furlong; D Mann; J F Powell
Journal:  Neurosci Lett       Date:  2001-02-16       Impact factor: 3.046

Review 6.  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

7.  Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.

Authors:  P Poorkaj; M Grossman; E Steinbart; H Payami; A Sadovnick; D Nochlin; T Tabira; J Q Trojanowski; S Borson; D Galasko; S Reich; B Quinn; G Schellenberg; T D Bird
Journal:  Arch Neurol       Date:  2001-03

8.  Genetic evidence for the involvement of tau in progressive supranuclear palsy.

Authors:  C Conrad; A Andreadis; J Q Trojanowski; D W Dickson; D Kang; X Chen; W Wiederholt; L Hansen; E Masliah; L J Thal; R Katzman; Y Xia; T Saitoh
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

9.  Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy.

Authors:  E Di Maria; M Tabaton; T Vigo; G Abbruzzese; E Bellone; C Donati; E Frasson; R Marchese; P Montagna; D G Munoz; P P Pramstaller; G Zanusso; F Ajmar; P Mandich
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

10.  Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.

Authors:  Victoria Zhukareva; David Mann; Stuart Pickering-Brown; Kunihiro Uryu; Theresa Shuck; Keyur Shah; Murray Grossman; Bruce L Miller; Christine M Hulette; Stuart C Feinstein; John Q Trojanowski; Virginia M-Y Lee
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

View more
  13 in total

Review 1.  Frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

Review 2.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

3.  H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers.

Authors:  Elisa Canu; Marina Boccardi; Roberta Ghidoni; Luisa Benussi; Cristina Testa; Michela Pievani; Matteo Bonetti; Giuliano Binetti; Giovanni B Frisoni
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

4.  The splicing regulatory protein p18SRP is down-regulated in Alzheimer's disease brain.

Authors:  Klaus Heese; Masako Fujita; Hiroyasu Akatsu; Takayuki Yamamoto; Kenji Kosaka; Yasuo Nagai; Tohru Sawada
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Association of GSK3B with Alzheimer disease and frontotemporal dementia.

Authors:  Barbara A J Schaffer; Lars Bertram; Bruce L Miller; Kristina Mullin; Sandra Weintraub; Nancy Johnson; Eileen H Bigio; Marsel Mesulam; Martina Wiedau-Pazos; George R Jackson; Jeffrey L Cummings; Rita M Cantor; Allan I Levey; Rudolph E Tanzi; Daniel H Geschwind
Journal:  Arch Neurol       Date:  2008-10

6.  Brain tau expression and correlation with the H1/H1 tau genotype in frontotemporal lobar degeneration patients.

Authors:  A Lladó; M Ezquerra; C Gaig; R Sánchez-Valle; E Tolosa; J L Molinuevo
Journal:  J Neural Transm (Vienna)       Date:  2007-07-30       Impact factor: 3.575

7.  Searching for Grendel: origin and global spread of the C9ORF72 repeat expansion.

Authors:  Hannah A Pliner; David M Mann; Bryan J Traynor
Journal:  Acta Neuropathol       Date:  2014-02-05       Impact factor: 17.088

Review 8.  Regulation of human MAPT gene expression.

Authors:  Marie-Laure Caillet-Boudin; Luc Buée; Nicolas Sergeant; Bruno Lefebvre
Journal:  Mol Neurodegener       Date:  2015-07-14       Impact factor: 14.195

Review 9.  Tau protein in familial and sporadic diseases.

Authors:  Despina Yancopoulou; Maria Grazia Spillantini
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

Review 10.  Tau mis-splicing in the pathogenesis of neurodegenerative disorders.

Authors:  Sun Ah Park; Sang Il Ahn; Jean-Marc Gallo
Journal:  BMB Rep       Date:  2016-08       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.